These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8925855)

  • 21. Simultaneous estimation of glomerular filtration rate and renal plasma flow.
    Fresco GF; DiGiorgio F; Curti GL
    J Nucl Med; 1995 Sep; 36(9):1701-6. PubMed ID: 7658234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man.
    Rehling M; Møller ML; Thamdrup B; Lund JO; Trap-Jensen J
    Clin Sci (Lond); 1984 May; 66(5):613-9. PubMed ID: 6423339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.
    Taylor AT; Lipowska M; Hansen L; Malveaux E; Marzilli LG
    J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR; Robbins MS
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reproducibility of single-sample clearance of 99mTc-mercaptoacetyltriglycine and 131I-orthoiodohippurate.
    Russell CD; Dubovsky EV
    J Nucl Med; 1999 Jul; 40(7):1122-4. PubMed ID: 10405130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
    Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE
    J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
    Mustafa S; Elgazzar AH
    J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume.
    Esteves FP; Taylor A; Manatunga A; Folks RD; Krishnan M; Garcia EV
    AJR Am J Roentgenol; 2006 Dec; 187(6):W610-7. PubMed ID: 17114514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproducibility of technetium-99m-MAG3 clearance using the Bubeck method.
    Werner E; Blasl C; Reiners C
    J Nucl Med; 1998 Jun; 39(6):1066-9. PubMed ID: 9627345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of technetium-99m-L,L-ethylenedicysteine in patients with chronic renal failure.
    Prvulovich EM; Bomanji JB; Waddington WA; Rudrasingham P; Verbruggen AM; Ell PJ
    J Nucl Med; 1997 May; 38(5):809-14. PubMed ID: 9170451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspects of osseous, peritoneal and renal handling of bisphosphonate during peritoneal dialysis: a methodological study.
    Joffe P; Henriksen JH
    Scand J Clin Lab Invest; 1996 Jul; 56(4):327-37. PubMed ID: 8837239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
    Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
    J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A direct in vivo measurement of 99mTc-methylene diphosphonate protein binding.
    Blake GM; Moore AE; Park-Holohan SJ; Fogelman I
    Nucl Med Commun; 2003 Jul; 24(7):829-35. PubMed ID: 12813203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal effects of low dose methotrexate in rheumatoid arthritis.
    Seideman P; Müller-Suur R; Ekman E
    J Rheumatol; 1993 Jul; 20(7):1126-8. PubMed ID: 8371203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducibility of a single-sample method for 99Tcm-MAG3 clearance under clinical conditions.
    Kotzerke J; Glatz S; Grillenberger K; Kleinschmidt K; Reske SN
    Nucl Med Commun; 1997 Apr; 18(4):352-7. PubMed ID: 9170621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
    Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
    Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of 51Cr-EDTA with 99m-Tc-DTPA slope clearance for estimation of glomerular filtration rate using the one compartment model].
    Chapot C; Seifert H; Samnick S; Kirsch CM
    Nuklearmedizin; 1998 Jun; 37(4):124-8. PubMed ID: 9650211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clearance of iohexol, 51Cr-EDTA and endogenous creatinine for determination of glomerular filtration rate in pigs with reduced renal function: a comparison between different clearance techniques.
    Frennby B; Sterner G; Almén T; Chai CM; Jönsson BA; Månsson S
    Scand J Clin Lab Invest; 1997 May; 57(3):241-52. PubMed ID: 9238760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A comparison of different methods of calculating clearances using 99mTc-mercaptoacetyltriglycine and 123I- or 131I-ortho-iodohippuric acid].
    Keske U; Cordes M; Hosten N; Roll D; Hunger J; Felix R
    Nuklearmedizin; 1990 Jun; 29(3):93-100. PubMed ID: 2144045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 99mTc-MAG3 versus 131I-orthoiodohippurate in the routine determination of effective renal plasma flow.
    Bagni B; Portaluppi F; Montanari L; Prandini N; Zatta G
    J Nucl Med Allied Sci; 1990; 34(2):67-70. PubMed ID: 2147211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.